SEC Form D · Amendment · filed August 29, 2017
IRX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Bill Flecky · Louisville, COExecPaul Lichty · Louisville, CODirectorBrad Beasecker · Columbus, OHDirectorDennis Townsend · Louisville, CODirectorJack Mcfarland · Louisville, CODirectorGanesh H. Betanabhatla · Houston, TXExecDavid King · Louisville, CODirectorAlexandra Waldman · New York, NYDirectorJerod Bowen · Chandler, AZExecJared D. Levin · Richmond, VADirectorMax D. Comess · Richmond, VADirectorAileen S. O'Toole · Amsterdam, P7DirectorLawrence C. Illg · Incline Village, NVDirectorJohn D. Harper · Las Vegas, NVDirectorJohn W. Copeland · Palm Beach, FLDirectorRichard S. Berg · Chicago, ILExecMark W. Leuchtenberger · New York, NYExec · DirectorEdmund W. Truell · New York, NYDirectorMonil W. Shah · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗